Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of sacubitril/valsartan according to polypharmacy status in PARAGON-HF.
Matsumoto S, Yang M, Shen L, Henderson A, Claggett BL, Desai AS, Lefkowitz M, Rouleau JL, Vardeny O, Zile MR, Jhund PS, Vaduganathan M, Solomon SD, McMurray JJV. Matsumoto S, et al. Among authors: mcmurray jjv. Eur J Heart Fail. 2024 Apr 8. doi: 10.1002/ejhf.3223. Online ahead of print. Eur J Heart Fail. 2024. PMID: 38587090
Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure.
Docherty KF, McDowell K, Welsh P, Osmanska J, Anand I, de Boer RA, Køber L, Kosiborod MN, Martinez FA, O'Meara E, Ponikowski P, Schou M, Berg DD, Sabatine MS, Morrow DA, Jarolim P, Hammarstedt A, Sjöstrand M, Langkilde AM, Solomon SD, Sattar N, Jhund PS, McMurray JJV. Docherty KF, et al. Among authors: mcmurray jjv. J Am Coll Cardiol. 2023 Jul 11;82(2):142-157. doi: 10.1016/j.jacc.2023.05.011. J Am Coll Cardiol. 2023. PMID: 37407113 Free article.
Global Comparison of Readmission Rates for Patients With Heart Failure.
Foroutan F, Rayner DG, Ross HJ, Ehler T, Srivastava A, Shin S, Malik A, Benipal H, Yu C, Alexander Lau TH, Lee JG, Rocha R, Austin PC, Levy D, Ho JE, McMurray JJV, Zannad F, Tomlinson G, Spertus JA, Lee DS. Foroutan F, et al. Among authors: mcmurray jjv. J Am Coll Cardiol. 2023 Aug 1;82(5):430-444. doi: 10.1016/j.jacc.2023.05.040. J Am Coll Cardiol. 2023. PMID: 37495280
Dapagliflozin in Patients With Heart Failure and Deterioration in Renal Function.
Chatur S, Vaduganathan M, Claggett BL, Mc Causland FR, Desai AS, Jhund PS, de Boer RA, Hernandez AF, Inzucchi SE, Kosiborod MN, Lam CSP, Martinez FA, Shah SJ, Sabatine MS, Kober L, Ponikowski P, Merkely B, Petersson M, Langkilde AM, McMurray JJV, Solomon SD. Chatur S, et al. Among authors: mcmurray jjv. J Am Coll Cardiol. 2023 Nov 7;82(19):1854-1863. doi: 10.1016/j.jacc.2023.08.026. Epub 2023 Aug 25. J Am Coll Cardiol. 2023. PMID: 37634707 Free article.
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.
Vissing CR, Axelsson Raja A, Day SM, Russell MW, Zahka K, Lever HM, Pereira AC, Colan SD, Margossian R, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Benson L, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Thrush P, Soslow JH, Becker JR, Seidman CE, Lakdawala NK, Cirino AL, McMurray JJV, MacRae CA, Solomon SD, Bundgaard H, Orav EJ, Ho CY; Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Investigators. Vissing CR, et al. Among authors: mcmurray jjv. JAMA Cardiol. 2023 Nov 1;8(11):1083-1088. doi: 10.1001/jamacardio.2023.2808. JAMA Cardiol. 2023. PMID: 37672268 Clinical Trial.
Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF.
Kondo T, Mogensen UM, Talebi A, Gasparyan SB, Campbell RT, Docherty KF, de Boer RA, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Sabatine MS, Bengtsson O, Sjöstrand M, Vaduganathan M, Solomon SD, Jhund PS, McMurray JJ. Kondo T, et al. J Am Coll Cardiol. 2024 Mar 25:S0735-1097(24)06671-3. doi: 10.1016/j.jacc.2024.03.385. Online ahead of print. J Am Coll Cardiol. 2024. PMID: 38537918 Free article.
1,159 results